Newsfile

The newsfeed available here is provided by our content partner Newswire Corp.. It is a major and wide-reaching newswire & news provider that provides information, press releases and multimedia content for media, journalists and the general public. ActusNews enjoys a high reputation and great popularity, especially among listed companies in its home market North America.

The NewsWire Hub ("X-Billboard") currently comprises six of the most important international news sources and is supplemented by a stock market information service and additional RNS News. The individual newswire services complement each other and form a complementary information offering that covers more than three quarters of the official news sources on which editorial offices worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 35
5.511,25 S&P · 23,80 Vola-Index · 95.405,11 BTC · 1,13608 EURUSD
System-State: Number of processed items 173.617 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              

Newsfile Corp. is an important, trusted and reliable news source for private investors, investors and traders, which can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. Those who want to take a closer look at the news can access the respective news item and other analysis tools directly via the detailed views of the info cards.

NEWS
EXPLORER
CA14161Y2006
State: 25.04.2025 | 8PM
Do you already know our new terminal view? Click here.
FIGI: BBG00M0GNP68
CRDL
Cardiol Therapeutics Inc.
GICS: - · Sector: Life Sciences · Sub-Sector: -
NAME
Cardiol Therapeutics Inc.
ISIN
CA14161Y2006
TICKER
CRDL
MIC
XTSX
REUTERS
CRDL.TO
BLOOMBERG
CRDL CN
Thu, 04.06.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - June 4, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to announce the closing of its previously announced "bought deal" short form pro...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Tue, 02.06.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - June 2, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, announces results from its Annual General Meeting ("AGM") of shareholders h...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Fri, 29.05.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - May 29, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to announce that it will webcast the Company's virtual Annua...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Thu, 14.05.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - May 14, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to announce that it has entered into an agreement with a syn...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 13.05.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - May 13, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to announce that it has entered into an agreement with Canaccord ...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 06.05.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - May 6, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to announce the filing of a new patent application covering the us...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Tue, 14.04.2020       Cardiol Therapeutics
CA14161Y2006

Results showed a greater than 100-fold increase in uptake of Cardiol's nanoparticles in heart failure hearts compared with control heartsOakville, Ontario--(Newsfile Corp. - April 14, 2020) -  Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) a...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 01.04.2020       Cardiol Therapeutics
CA14161Y2006

Data Accepted for Presentation at the American College of Cardiology Annual MeetingOakville, Ontario--(Newsfile Corp. - April 1, 2020) -  Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for h...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Thu, 26.03.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - March 26, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, today filed its audited Year-end Financial Statements and Management's Dis...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 18.03.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - March 18, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart disease, is pleased to announce that it has signed a supplier agreement to offer its...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Thu, 05.03.2020       Cardiol Therapeutics
CA14161Y2006

Study represents the first Canadian clinical trial of an oral pharmaceutical cannabidiol product specifically formulated for patients who should not be exposed to THCOakville, Ontario--(Newsfile Corp. - March 5, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical c...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Wed, 15.01.2020       Cardiol Therapeutics
CA14161Y2006

Oakville, Ontario--(Newsfile Corp. - January 15, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, is pleased to announce that its exclusive manufacturing partner, Dalton...
Read More
Cardiol Therapeutics
Technical Analysis Termsheet Terminal
Permalink

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the international investor community, we would like to thank Newswire Corp. for providing the news and data feeds